Determination of TBI-166, a Novel Antituberculotic, in Rat Plasma by Liquid Chromatography–Tandem Mass Spectrometry

Dan Li,Li Sheng,Xin Liu,Shuang Yang,Zhihao Liu,Yan Li
DOI: https://doi.org/10.1007/s10337-014-2771-0
2014-01-01
Chromatographia
Abstract:A rapid and sensitive liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for the determination of TBI-166 in rat plasma was developed and validated. Propranolol was used as the internal standard (IS). Plasma samples containing TBI-166 and IS were prepared based on a simple protein precipitation by the addition of ten volumes of acetonitrile. Thermo Scientific TSQ Quantum triple quadrupole system with multiple reaction monitoring (MRM) positive scanning mode was applied. The monitored transitions were 590 → 478 for TBI-166 and 260 → 183 for IS. The separation was performed on a Symmetry C8 column (3.5 μm, 2.1 × 50 mm) with the mobile phase of acetonitrile/water containing 0.1 % formic acid (v/v) with gradient elution at a flow rate of 0.2 mL/min. Linear detection responses were obtained for TBI-166 ranging from 5 to 2000 ng/mL and the lower limit of quantitation (LLOQ) was 5 ng/mL. The intra- and inter-day precisions (RSD) were all within 7.2 %, while the deviation of assay accuracies was equal to or lower than ±5.5 %. The average recoveries of analyte were greater than 95.2 %. The analyte was proved to be stable during all sample storage, preparation and analytic procedures. The optimized method was successfully applied to the pharmacokinetic studies of TBI-166 in rats.
What problem does this paper attempt to address?